American Century Companies Inc Chemo Centryx, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

Shares

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 05, 2021	SELL	$9.59 - $50.88 $1.74 Million - $9.23 Million	-181,365 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$49.53 - $68.4 $778,066 - $1.07 Million	15,709 Added 9.48%	181,365 $9.29 Million
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $155,925 - $215,028	-3,300 Reduced 1.95%	165,656 $10.3 Million
Q3 2020 Nov 13, 2020	BUY	$46.35 - $61.69 $1.16 Million - $1.54 Million	24,920 Added 17.3%	168,956 $9.26 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $1.02 Million - $1.72 Million	26,493 Added 22.54%	144,036 $8.29 Million
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $80,024 - $124,157	2,445 Added 2.12%	117,543 $4.72 Million
Q4 2019 Feb 12, 2020	BUY	$6.81 - $39.55 $335,807 - $1.95 Million	49,311 Added 74.96%	115,098 $4.55 Million
Q4 2018 Feb 13, 2019	SELL	$9.15 - $12.26 $944,737 - $1.27 Million	-103,250 Reduced 61.08%	65,787 $718,000
Q3 2018 Nov 02, 2018	BUY	$10.49 - $13.72 $54,191 - $70,877	5,166 Added 3.15%	169,037 $2.14 Million
Q2 2018 Aug 08, 2018	BUY	$10.62 - $13.98 $1.41 Million - $1.85 Million	132,592 Added 423.9%	163,871 $2.16 Million
Q1 2018 May 03, 2018	BUY	$5.9 - $14.99 $184,546 - $468,872	31,279 New	31,279 $425,000
Q4 2017 Feb 02, 2018	SELL	$5.53 - $8.42 $199,030 - $303,044	-35,991 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$6.5 - $10.69 $233,941 - $384,743	35,991	35,991 $267,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.